Related references
Note: Only part of the references are listed.Targeting tumor lineage plasticity in hepatocellular carcinoma using an anti-CLDN6 antibody-drug conjugate
Fan-En Kong et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Aberrant Claudin-6-Adhesion Signaling Promotes Endometrial Cancer Progression via Estrogen Receptor α
Manabu Kojima et al.
MOLECULAR CANCER RESEARCH (2021)
The Expression of CLDN6 in Hepatocellular Carcinoma Tissue and the Effects of CLDN6 on Biological Phenotypes of Hepatocellular Carcinoma Cells
Yan Lu et al.
JOURNAL OF CANCER (2021)
Downregulation of CLDN6 inhibits cell proliferation, migration, and invasion via regulating EGFR/AKT/mTOR signalling pathway in hepatocellular carcinoma
Lingyuan Huang et al.
CELL BIOCHEMISTRY AND FUNCTION (2020)
Macrophage migration inhibitory factor is differentially expressed in normal and choriocarcinoma trophoblast cells
A. Vilotic et al.
NEOPLASMA (2020)
Estrogen receptor β inhibits breast cancer cells migration and invasion through CLDN6-mediated autophagy
Peiye Song et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Gestational Trophoblastic Tumors A Timely Review of Diagnostic Pathology
Pei Hui
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2019)
CLDN6 promotes tumor progression through the YAP1-snaill axis in gastric cancer
Site Yu et al.
CELL DEATH & DISEASE (2019)
Evaluation and suggestions for improving the FIGO 2000 staging criteria for gestational trophoblastic neoplasia: A ten-year review of 1420 patients
Fang Jiang et al.
GYNECOLOGIC ONCOLOGY (2018)
Cancer stem cells revisited
Eduard Batlle et al.
NATURE MEDICINE (2017)
Ovarian cancer stem cells more questions than answers
Petronella Beatrix Ottevanger
SEMINARS IN CANCER BIOLOGY (2017)
Insights into dovetailing GTD and Cancers
Revathy Nadhan et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
Echoes of the embryo: using the developmental biology toolkit to study cancer
Nicole M. Aiello et al.
DISEASE MODELS & MECHANISMS (2016)
Fatal gestational trophoblastic neoplasia: An analysis of treatment failures at the Brewer Trophoblastic Disease Center from 1979-2012 compared to 1962-1978
Nikki L. Neubauer et al.
GYNECOLOGIC ONCOLOGY (2015)
Utility of hCG dosage in the management of gestational trophoblastic diseases
Alban Gildas Comlan Zohoun et al.
ANNALES DE BIOLOGIE CLINIQUE (2013)
Claudin-6 is a Nonspecific Marker for Malignant Rhabdoid and Other Pediatric Tumors
Lisa M. Sullivan et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
Distinct expression pattern of claudin-6, a primitive phenotypic tight junction molecule, in germ cell tumours and visceral carcinomas
Tetsuo Ushiku et al.
HISTOPATHOLOGY (2012)
Tight junction protein, claudin-6, downregulates the malignant phenotype of breast carcinoma
Qiong Wu et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2010)
Structure and function of claudins
Gerd Krause et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2008)
Genetic targeting of the endoderm with Claudin-6CreER
William J. Anderson et al.
DEVELOPMENTAL DYNAMICS (2008)
Claudins: multifunctional players in epithelial tight junctions and their role in cancer
S. S. Oliveira et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
The classification, functions and clinical use of different isoforms of HCG
Ulf-Hakan Stenman et al.
HUMAN REPRODUCTION UPDATE (2006)
The transcription factor Snail downregulates the tight junction components independently of E-cadherin downregulation
T Ohkubo et al.
JOURNAL OF CELL SCIENCE (2004)
Human chorionic gonadotropin in cancer
UH Stenman et al.
CLINICAL BIOCHEMISTRY (2004)
Claudin-6: A novel tight junction molecule is developmentally regulated in mouse embryonic epithelium
K Turksen et al.
DEVELOPMENTAL DYNAMICS (2001)
Share Paper
